๐ŸŒ icotrokinra

organization

Icotrokinra is an investigational oral peptide drug targeting the interleukin-23 receptor, monitored globally for developments in clinical trials, regulatory review, and potential use in treating immune-mediated diseases.

1
Signals
1
Articles

Linked Signals

SignalStatusLensRoleConfidenceLast Seen
Allergan Aesthetics presents data on facial injectables at Dubai expired Health involved 100%